SI-Bone reported second-quarter worldwide revenue of $56 million, up 15.2% year over year, and raised its full-year 2026 revenue guidance to $231 million to $233 million.
U.S. revenue increased 14.7% to $53.2 million, while international revenue rose 25.9% to $2.8 million, according to an Aug. 3 news release from the company.
SI-Bone said 1,715 active U.S. physicians utilize its products, up 19% from the prior-year period, and submitted a 510(k) application in June for its third breakthrough device targeting spine surgery. CMS also finalized a new MS-DRG family providing higher payments for complex spinal fusion procedures incorporating iFuse Bedrock Granite in the inpatient setting, effective Oct. 1.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.